Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus ropivacaine pudendal nerve block after mixed hemorrhoid surgery
ChiCTR2600133148Phase 4Completed
- Sponsor
- Songzi Hospital of TCM
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine and ropivacaine in postoperative pain (2 arms), sponsored by Songzi Hospital of TCM. Primary endpoint: Resting Numeric Rating Scale for Pain. Started Sep 2025; status: completed.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600133148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133148.